Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer

Autor:	Jialong Han, Yu Sun, Yan Wang, Lili Zhong, Jiaojiao Suo, Huijie Zhou, Hao Wei, Jiang Zhu, Weigang Xiu
Rok vydání:	2020
Předmět:	Adult Male 0301 basic medicine Oncology Target lesion Cancer Research medicine.medical_specialty Lung Neoplasms medicine.medical_treatment Disease 03 medical and health sciences Antineoplastic Agents Immunological 0302 clinical medicine Carcinoma Non-Small-Cell Lung Internal medicine Antineoplastic Combined Chemotherapy Protocols Humans Medicine Lung cancer Aged Retrospective Studies Hematology business.industry General Medicine Immunotherapy Middle Aged medicine.disease 030104 developmental biology Response Evaluation Criteria in Solid Tumors 030220 oncology & carcinogenesis Propensity score matching Cohort Disease Progression Female business
Zdroj:	Journal of Cancer Research and Clinical Oncology. 146:2979-2988
ISSN:	1432-1335 0171-5216
DOI:	10.1007/s00432-020-03282-y
Popis:	Dissociated response (DR, reduction at baseline or increase
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3975414976212048197a873fcc0835c https://doi.org/10.1007/s00432-020-03282-y Zobrazit plný text záznamu Full text from SpringerLink